New Jersey Senator panel advances bill legalizing ‘magic mushrooms’ for therapeutic use | Cannabis Law Report | Where to order Skittles Moonrock online

Learn where to buy marijuana online. TOP QUALITY GRADE A++

Cannabyss Inc. is the best place online to buy top quality weed, cannabis, vape, marijuana and CBD products. Get your borderless orders delivered at the pickup spot with ease. Top Grade products for client satisfaction.

👉 Click here to Visit our shop! 🛒

Header Image: Sen. Paul Sarlo (D-Bergen)

NJ Monitor

“We need to always keep our minds open and allow experts to continue to find ways to treat mental health,” said Sen. Paul Sarlo (D-Bergen), the committee’s chair.

The amended bill advanced Monday focuses largely on therapeutic access for adults over 21. A previous version of the bill, sponsored by Senate President Nicholas Scutari (D-Union), included provisions that would have allowed adults to possess up to four grams of psilocybin.

The measure, as amended, would still put New Jersey at the forefront of regulating the use of psilocybin for health care treatments. Oregon and Colorado have both legalized psilocybin treatment for therapeutic uses and research.

Multiple studies have found one dose of the psychedelic drug can have a wide range of health benefits, ranging from easing emotional distress in people with cancer to relieving symptoms of major depressive disorder.

The bill would create a 15-member advisory board that includes representatives from the Department of Health and nine gubernatorial appointees with experience in psychedelic-assisted therapy. During an 18-month period, they’d issue recommendations on the implementation of the bill, including:

• Requirements, specifications, and guidelines for providing psilocybin to a patient.
• Public health and safety standards.
• A code of professional conduct.
• Exams that psilocybin facilitators would be required to take as a condition of licensure.
• Qualifications and cost for license applications and issuances fees.
• Requirements for tracking psilocybin products, including transportation and delivery between businesses.
• Requirements for a “social opportunity and equitable access program.”

Licensing can begin after the 18-month period but no later than 24 months after the effective date of the bill. At that point, state health officials would be tasked with licensing and regulating the manufacture, transport, delivery, testing, sale, and purchase of psilocybin. Licenses could be issued for psilocybin product manufacturers, service center operators, testing laboratories, psilocybin facilitators, and workers.

Read More